Reaction
Uterine Disorder reporting signals
As of the last recalculation, Uterine Disorder appears in 2,315 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is TRANEXAMIC ACID (PRR 23.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tranexamic Acid | 23 | 23.5 | 23.5 |
| Alendronate Sodium | 222 | 21.8 | 21.8 |
| Misoprostol | 15 | 13.9 | 14.0 |
| Risedronate Sodium | 42 | 12.4 | 12.4 |
| Conjugated Estrogens | 69 | 10.9 | 11.0 |
| Estrogens, Conjugated | 69 | 10.7 | 10.8 |
| Ozanimod Hydrochloride | 9 | 9.8 | 9.8 |
| Progesterone | 24 | 9.5 | 9.5 |
| Copper | 40 | 8.5 | 8.5 |
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 8 | 8.4 | 8.4 |
| Medroxyprogesterone Acetate | 44 | 8.1 | 8.1 |
| Abatacept | 108 | 7.3 | 7.3 |
| Buprenorphine Hydrochloride, Naloxone Hydrochloride | 16 | 6.0 | 6.0 |
| Agalsidase Beta | 6 | 5.8 | 5.9 |
| Estradiol | 55 | 5.8 | 5.8 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 15 | 5.7 | 5.7 |
| Levonorgestrel | 110 | 5.1 | 5.1 |
| Etonogestrel And Ethinyl Estradiol | 12 | 4.9 | 4.9 |
| Interferon Beta-1A | 97 | 4.7 | 4.7 |
| Ocrelizumab | 26 | 3.8 | 3.8 |
| Dofetilide | 4 | 3.4 | 3.4 |
| Teriflunomide | 14 | 2.8 | 2.8 |
| Lenalidomide | 109 | 2.4 | 2.4 |
| Etonogestrel | 11 | 2.1 | 2.1 |
| Apremilast | 29 | 1.8 | 1.8 |